Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

CVS Health Corporation (CVS) had Revenue of $94.59B for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$94.59B
Net Income	$1.78B
Cost of Goods Sold	$51.06B
Gross Profit	$43.53B
Operating Expenses	$91.21B
Operating Income	$3.37B
Non-Operating Income/Expense	$-757.00M
Pre-Tax Income	$2.62B
Normalized Pre-Tax Income	$2.62B
Income after Taxes	$1.78B
Income from Continuous Operations	$1.78B
Consolidated Net Income/Loss	$1.78B
Normalized Income after Taxes	$1.78B
EBIT	$3.37B
EBITDA	$4.53B
Weighted-Average Shares Outstanding (Basic)	1.26B
Weighted-Average Shares Outstanding (Diluted)	1.26B
Earnings per Share (EPS) (Basic)	$1.41
Earnings per Share (EPS) (Diluted)	$1.41
Balance Sheet Financials
Current Assets	$73.19B
Property, Plant, and Equipment	$12.86B
Long-Term Assets	$182.39B
Total Assets	$255.59B
Current Liabilities	$88.96B
Long-Term Debt	$59.04B
Long-Term Liabilities	$89.51B
Total Liabilities	$178.47B
Common Equity	$77.11B
Tangible Shareholders Equity	$-40.66B
Shareholders Equity	$77.11B
Common Shares Outstanding	1.26B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$4.56B
Cash Flow from Investing Activities	$-762.00M
Cash Flow from Financial Activities	$-2.33B
Beginning Cash	$8.88B
End Cash	$10.35B
Increase/Decrease in Cash	$1.46B
Stock-Based Compensation	$126.00M
Common Stock Dividends Paid	$-840.00M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.82
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.43
Debt to Equity Ratio	0.84
Gross Margin	46.02%
Operating Margin	3.57%
EBIT Margin	3.57%
EBITDA Margin	--
Pre-Tax Profit Margin	2.77%
Profit Margin	1.88%
Free Cash Flow	$3.81B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.37
Inventory Turnover	2.94
Receiveable Turnover	2.39
Days Sales in Receivables	37.70
Return on Equity	2.31%
Return on Tangible Equity	-4.38%
Return on Assets	0.70%
Return on Investments	1.31%
Book Value Per Share	$61.10
Free Cash Flow per Share	$3.02
Operating Cash Flow per Share	$3.60

Data from Zacks Investment Research, Inc.